Report Top Up a Page Previous Next Up a Map TOC Page Index File Index What's New Page Bottom
Cognigen Corporation - Posters and Presentations : Pre-2006 : 2002 : IDSA 2002 : Minimum Efficacy and Mutation Prevention Exposure Target Attainment Rates Against Streptococcus pneumoniae for Levofloxacin 500 mg and 750 mg and Moxifloxacin 400 mg published Mon, Nov 10, 2008 - 15:27 EST

Minimum Efficacy and Mutation Prevention Exposure Target Attainment Rates Against Streptococcus pneumoniae for Levofloxacin 500 mg and 750 mg and Moxifloxacin 400 mg

Primary Author: RC Owens; Primary Cognigen Author: Paul G. Ambrose

Reprint currently not available.

Page authored by Cognigen Corporation

Cognigen Corporation - Posters and Presentations : Pre-2006 : 2002 : IDSA 2002 : Minimum Efficacy and Mutation Prevention Exposure Target Attainment Rates Against Streptococcus pneumoniae for Levofloxacin 500 mg and 750 mg and Moxifloxacin 400 mg published Mon, Nov 10, 2008 - 15:27 EST
Report Top Up a Page Previous Next Up a Map TOC Page Index File Index What's New Page Top